<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Thu, 16 Oct 2025 06:55:46 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Merck updates healthcare guidance, eyes 100bps margin expansion; shares drop</title>
   <link>http://www.streetinsider.com/Investing/Merck+updates+healthcare+guidance%2C+eyes+100bps+margin+expansion%3B+shares+drop/25463050.html</link>
   <description>&lt;p&gt;Investing.com -- Merck KGaA hiked its mid-term growth ambitions for its healthcare unit ahead of its capital markets day (CMD), saying it now expects annual organic sales to rise in the low- to mid single-digit percentage range. It previously guided for “slight growth.”&lt;/p&gt;
&lt;p&gt;Life science is now seen growing in the mid- to high single digits, compared with a 7% to 9% goal previously.&lt;/p&gt;
&lt;p&gt;Groupwide, the company is targeting mid single-digit organic sales growth over the period.&lt;/p&gt;
&lt;p&gt;Merck also expects its EBITDA pre-margin to widen by around 100 basis points over the period.&lt;/p&gt;
&lt;p&gt;The company’s shares fell nearly 3% in Frankfurt trading. &lt;/p&gt;
&lt;p&gt;The company confirmed</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Investing/Merck+updates+healthcare+guidance%2C+eyes+100bps+margin+expansion%3B+shares+drop/25463050.html</guid>
   <pubDate>Thu, 16 Oct 2025 06:55:46 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MRCG</category>
   	  </item>
  <item>
   <title>Merck updates healthcare guidance, eyes 100bps margin expansion; shares drop</title>
   <link>http://www.streetinsider.com/General+News/Merck+updates+healthcare+guidance%2C+eyes+100bps+margin+expansion%3B+shares+drop/25463050.html</link>
   <description>&lt;p&gt;Investing.com -- Merck KGaA hiked its mid-term growth ambitions for its healthcare unit ahead of its capital markets day (CMD), saying it now expects annual organic sales to rise in the low- to mid single-digit percentage range. It previously guided for “slight growth.”&lt;/p&gt;
&lt;p&gt;Life science is now seen growing in the mid- to high single digits, compared with a 7% to 9% goal previously.&lt;/p&gt;
&lt;p&gt;Groupwide, the company is targeting mid single-digit organic sales growth over the period.&lt;/p&gt;
&lt;p&gt;Merck also expects its EBITDA pre-margin to widen by around 100 basis points over the period.&lt;/p&gt;
&lt;p&gt;The company’s shares fell nearly 3% in Frankfurt trading. &lt;/p&gt;
&lt;p&gt;The company confirmed</description>
   <guid isPermaLink="true">http://www.streetinsider.com/General+News/Merck+updates+healthcare+guidance%2C+eyes+100bps+margin+expansion%3B+shares+drop/25463050.html</guid>
   <pubDate>Thu, 16 Oct 2025 06:55:46 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MRCG</category>
   	  </item>
  <item>
   <title>SpringWorks Therapeutics springs higher as Merck KGaA takeover said close</title>
   <link>http://www.streetinsider.com/Investing/SpringWorks+Therapeutics+springs+higher+as+Merck+KGaA+takeover+said+close/24683143.html</link>
   <description>&lt;p&gt;Investing.com -- Shares of &lt;span itemscope=&quot;&quot; itemtype=&quot;http://schema.org/Corporation&quot;&gt;&lt;span itemprop=&quot;name&quot;&gt; SpringWorks Therapeutics Inc &lt;/span&gt;&lt;/span&gt; (NASDAQ:SWTX) surged higher Thursday afternoon on reports that a potential takeover of the company by Germany’s Merck KGaA (ETR:MRCG) is getting close.&lt;/p&gt;&lt;p&gt;This afternoon, The Wall Street Journal reported that the two companies are near a $47 per share takeover deal and a definitive agreement could be announced as soon as Monday, citing people familiar with the matter.&lt;/p&gt;&lt;p&gt;Shares of SpringWorks last traded up 8% to $44.50.&lt;/p&gt;&lt;p&gt;The potential deal has been in the works since at least February, when Merck KGaA confirmed it was in advanced talks to acquire the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Investing/SpringWorks+Therapeutics+springs+higher+as+Merck+KGaA+takeover+said+close/24683143.html</guid>
   <pubDate>Thu, 24 Apr 2025 15:32:01 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MKKGY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRCG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SWTX</category>
   	  </item>
  <item>
   <title>SpringWorks Therapeutics springs higher as Merck KGaA takeover said close</title>
   <link>http://www.streetinsider.com/Mergers+and+Acquisitions/SpringWorks+Therapeutics+springs+higher+as+Merck+KGaA+takeover+said+close/24683143.html</link>
   <description>&lt;p&gt;Investing.com -- Shares of &lt;span itemscope=&quot;&quot; itemtype=&quot;http://schema.org/Corporation&quot;&gt;&lt;span itemprop=&quot;name&quot;&gt; SpringWorks Therapeutics Inc &lt;/span&gt;&lt;/span&gt; (NASDAQ:SWTX) surged higher Thursday afternoon on reports that a potential takeover of the company by Germany’s Merck KGaA (ETR:MRCG) is getting close.&lt;/p&gt;&lt;p&gt;This afternoon, The Wall Street Journal reported that the two companies are near a $47 per share takeover deal and a definitive agreement could be announced as soon as Monday, citing people familiar with the matter.&lt;/p&gt;&lt;p&gt;Shares of SpringWorks last traded up 8% to $44.50.&lt;/p&gt;&lt;p&gt;The potential deal has been in the works since at least February, when Merck KGaA confirmed it was in advanced talks to acquire the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Mergers+and+Acquisitions/SpringWorks+Therapeutics+springs+higher+as+Merck+KGaA+takeover+said+close/24683143.html</guid>
   <pubDate>Thu, 24 Apr 2025 15:32:01 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MKKGY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRCG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SWTX</category>
   	  </item>
  <item>
   <title>SpringWorks Therapeutics springs higher as Merck KGaA takeover said close</title>
   <link>http://www.streetinsider.com/Investing/SpringWorks+Therapeutics+springs+higher+as+Merck+KGaA+takeover+said+close/24683143.html</link>
   <description>&lt;p&gt;Investing.com -- Shares of &lt;span itemscope=&quot;&quot; itemtype=&quot;http://schema.org/Corporation&quot;&gt;&lt;span itemprop=&quot;name&quot;&gt; SpringWorks Therapeutics Inc &lt;/span&gt;&lt;/span&gt; (NASDAQ:SWTX) surged higher Thursday afternoon on reports that a potential takeover of the company by Germany’s Merck KGaA (ETR:MRCG) is getting close.&lt;/p&gt;&lt;p&gt;This afternoon, The Wall Street Journal reported that the two companies are near a $47 per share takeover deal and a definitive agreement could be announced as soon as Monday, citing people familiar with the matter.&lt;/p&gt;&lt;p&gt;Shares of SpringWorks last traded up 8% to $44.50.&lt;/p&gt;&lt;p&gt;The potential deal has been in the works since at least February, when Merck KGaA confirmed it was in advanced talks to acquire the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Investing/SpringWorks+Therapeutics+springs+higher+as+Merck+KGaA+takeover+said+close/24683143.html</guid>
   <pubDate>Thu, 24 Apr 2025 15:32:01 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MKKGY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRCG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SWTX</category>
   	  </item>
  <item>
   <title>SpringWorks Therapeutics springs higher as Merck KGaA takeover said close</title>
   <link>http://www.streetinsider.com/Mergers+and+Acquisitions/SpringWorks+Therapeutics+springs+higher+as+Merck+KGaA+takeover+said+close/24683143.html</link>
   <description>&lt;p&gt;Investing.com -- Shares of &lt;span itemscope=&quot;&quot; itemtype=&quot;http://schema.org/Corporation&quot;&gt;&lt;span itemprop=&quot;name&quot;&gt; SpringWorks Therapeutics Inc &lt;/span&gt;&lt;/span&gt; (NASDAQ:SWTX) surged higher Thursday afternoon on reports that a potential takeover of the company by Germany’s Merck KGaA (ETR:MRCG) is getting close.&lt;/p&gt;&lt;p&gt;This afternoon, The Wall Street Journal reported that the two companies are near a $47 per share takeover deal and a definitive agreement could be announced as soon as Monday, citing people familiar with the matter.&lt;/p&gt;&lt;p&gt;Shares of SpringWorks last traded up 8% to $44.50.&lt;/p&gt;&lt;p&gt;The potential deal has been in the works since at least February, when Merck KGaA confirmed it was in advanced talks to acquire the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Mergers+and+Acquisitions/SpringWorks+Therapeutics+springs+higher+as+Merck+KGaA+takeover+said+close/24683143.html</guid>
   <pubDate>Thu, 24 Apr 2025 15:32:01 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MKKGY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRCG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SWTX</category>
   	  </item>
  <item>
   <title>SpringWorks Therapeutics springs higher as Merck KGaA takeover said close</title>
   <link>http://www.streetinsider.com/Investing/SpringWorks+Therapeutics+springs+higher+as+Merck+KGaA+takeover+said+close/24683143.html</link>
   <description>&lt;p&gt;Investing.com -- Shares of &lt;span itemscope=&quot;&quot; itemtype=&quot;http://schema.org/Corporation&quot;&gt;&lt;span itemprop=&quot;name&quot;&gt; SpringWorks Therapeutics Inc &lt;/span&gt;&lt;/span&gt; (NASDAQ:SWTX) surged higher Thursday afternoon on reports that a potential takeover of the company by Germany’s Merck KGaA (ETR:MRCG) is getting close.&lt;/p&gt;&lt;p&gt;This afternoon, The Wall Street Journal reported that the two companies are near a $47 per share takeover deal and a definitive agreement could be announced as soon as Monday, citing people familiar with the matter.&lt;/p&gt;&lt;p&gt;Shares of SpringWorks last traded up 8% to $44.50.&lt;/p&gt;&lt;p&gt;The potential deal has been in the works since at least February, when Merck KGaA confirmed it was in advanced talks to acquire the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Investing/SpringWorks+Therapeutics+springs+higher+as+Merck+KGaA+takeover+said+close/24683143.html</guid>
   <pubDate>Thu, 24 Apr 2025 15:32:01 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MKKGY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRCG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SWTX</category>
   	  </item>
  <item>
   <title>SpringWorks Therapeutics springs higher as Merck KGaA takeover said close</title>
   <link>http://www.streetinsider.com/Mergers+and+Acquisitions/SpringWorks+Therapeutics+springs+higher+as+Merck+KGaA+takeover+said+close/24683143.html</link>
   <description>&lt;p&gt;Investing.com -- Shares of &lt;span itemscope=&quot;&quot; itemtype=&quot;http://schema.org/Corporation&quot;&gt;&lt;span itemprop=&quot;name&quot;&gt; SpringWorks Therapeutics Inc &lt;/span&gt;&lt;/span&gt; (NASDAQ:SWTX) surged higher Thursday afternoon on reports that a potential takeover of the company by Germany’s Merck KGaA (ETR:MRCG) is getting close.&lt;/p&gt;&lt;p&gt;This afternoon, The Wall Street Journal reported that the two companies are near a $47 per share takeover deal and a definitive agreement could be announced as soon as Monday, citing people familiar with the matter.&lt;/p&gt;&lt;p&gt;Shares of SpringWorks last traded up 8% to $44.50.&lt;/p&gt;&lt;p&gt;The potential deal has been in the works since at least February, when Merck KGaA confirmed it was in advanced talks to acquire the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Mergers+and+Acquisitions/SpringWorks+Therapeutics+springs+higher+as+Merck+KGaA+takeover+said+close/24683143.html</guid>
   <pubDate>Thu, 24 Apr 2025 15:32:01 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MKKGY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRCG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SWTX</category>
   	  </item>
 </channel>
</rss>
